Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
K Vijay - International immunopharmacology, 2018 - Elsevier
The immune system is a very diverse system of the host that evolved during evolution to
cope with various pathogens present in the vicinity of environmental surroundings inhabited …
cope with various pathogens present in the vicinity of environmental surroundings inhabited …
New-age vaccine adjuvants, their development, and future perspective
In the present scenario, immunization is of utmost importance as it keeps us safe and
protects us from infectious agents. Despite the great success in the field of vaccinology …
protects us from infectious agents. Despite the great success in the field of vaccinology …
[HTML][HTML] Modulating Th2 cell immunity for the treatment of asthma
B León, A Ballesteros-Tato - Frontiers in immunology, 2021 - frontiersin.org
It is estimated that more than 339 million people worldwide suffer from asthma. The leading
cause of asthma development is the breakdown of immune tolerance to inhaled allergens …
cause of asthma development is the breakdown of immune tolerance to inhaled allergens …
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
AM Didierlaurent, B Laupèze, A Di Pasquale… - Expert review of …, 2017 - Taylor & Francis
Introduction: Adjuvants are used to improve vaccine immunogenicity and efficacy by
enhancing antigen presentation to antigen-specific immune cells with the aim to confer long …
enhancing antigen presentation to antigen-specific immune cells with the aim to confer long …
Lipid-based nanoparticles for delivery of vaccine adjuvants and antigens: toward multicomponent vaccines
D Chatzikleanthous, DT O'Hagan… - Molecular …, 2021 - ACS Publications
Despite the many advances that have occurred in the field of vaccine adjuvants, there are
still unmet needs that may enable the development of vaccines suitable for more …
still unmet needs that may enable the development of vaccines suitable for more …
AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity
AM Didierlaurent, S Morel, L Lockman… - The Journal of …, 2009 - journals.aai.org
Abstract Adjuvant System 04 (AS04) combines the TLR4 agonist MPL (3-O-desacyl-4′-
monophosphoryl lipid A) and aluminum salt. It is a new generation TLR-based adjuvant …
monophosphoryl lipid A) and aluminum salt. It is a new generation TLR-based adjuvant …
Lipid A modification systems in gram-negative bacteria
CRH Raetz, CM Reynolds, MS Trent… - Annu. Rev …, 2007 - annualreviews.org
The lipid A moiety of lipopolysaccharide forms the outer monolayer of the outer membrane of
most gram-negative bacteria. Escherichia coli lipid A is synthesized on the cytoplasmic …
most gram-negative bacteria. Escherichia coli lipid A is synthesized on the cytoplasmic …
TLR-based immune adjuvants
F Steinhagen, T Kinjo, C Bode, DM Klinman - Vaccine, 2011 - Elsevier
This work describes the nature and strength of the immune response induced by various Toll-
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …
Norovirus vaccine against experimental human Norwalk Virus illness
RL Atmar, DI Bernstein, CD Harro… - … England Journal of …, 2011 - Mass Medical Soc
Background Noroviruses cause epidemic and sporadic acute gastroenteritis. No vaccine is
available to prevent norovirus illness or infection. Methods We conducted a randomized …
available to prevent norovirus illness or infection. Methods We conducted a randomized …
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
The inflammatory toxicity of lipopolysaccharide (LPS), a component of bacterial cell walls, is
driven by the adaptor proteins myeloid differentiation factor 88 (MyD88) and Toll-interleukin …
driven by the adaptor proteins myeloid differentiation factor 88 (MyD88) and Toll-interleukin …